Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents

Drug Metabolism Letters

Volumn 3, Issue 1, 2009, Pages 35-44

  Boutaleb Charki, Samira ^a   Marín, Clotilde ^a   Maldonado, Carmen R ^a   Rosales, María J ^a   Urbano, Jesus ^a   Guitierrez Sánchez, Ramon ^a   Quirós, Miguel ^a   Salas, Juan M ^a   Sánchez Moreno, Manuel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE COPPER; 1,2,4 TRIAZOLO[1,5 A]PYRIMIDINE COPPER; 5,7 DIMETHYL 1,2,4 TRIAZOLO[1,5 A]PYRIMIDINE COPPER; BENZNIDAZOLE; MEGLUMINE ANTIMONATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRIMIDINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENERGY METABOLISM; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEISHMANIA; MICROBIAL METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; ANTIPARASITIC AGENTS; CERCOPITHECUS AETHIOPS; COPPER; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; ENERGY METABOLISM; INDICATORS AND REAGENTS; LEISHMANIA; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, MOLECULAR; NAD; ORGANOMETALLIC COMPOUNDS; PYRIMIDINES; TRIAZOLES; TRYPANOSOMA CRUZI; VERO CELLS;

LEISHMANIA PERUVIANA; TRYPANOSOMA CRUZI;

EID: 66149123018     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231209787176317     Document Type: Article

References (31)

1. World Health Organization. Thirteenth Program Report, UNDP/World Bank/ World Health Organization program for research and training in tropical diseases. World Health Organization: Geneva. 1997.
2. WHO/CSR/EDC - UNAIDS. Map production: Public Health Mapping Group Communicable Diseases (CDS) World Health Organization. 2003.
3. Herwald, B. L. Leishmaniasis. Lancet, 1999, 354(2), 1191-1199.
4. Urbina, J.; Concepcion, J. L.; Rangel, S.; Visbal, G.; Lira, R. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. Mol. Biochem. Parasitol., 2002, 125(1-2), 35-45.
5. Boiani, M.; Boiani, L.; Denicola, A.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H.; Rojas de Arias, A.; Vega, C.; Rolan, M.; Gomez-Barrio, A.; Cerecetto, H.; Gonzalez, M. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents. J. Med. Chem., 2006, 49(11), 3215-3224.
6. Guerin, P. J.; Olliaro, P.; Sundar, S.; Boelaert, M.; Croft, S. L.; Desjeux, P.; Wasunna, K.; Bryceson, A. D. M. Visceral leishmaniasis: Current status of control, diagnosis and treatment, and a proposed research and development agenda. Lancet Infect. Dis., 2002, 2(8), 494-501.
7. Rosenthal, E.; Marty, P. Recent understanding in the treatment of visceral leishmaniasis. J. Postgrad. Med., 2003, 49(1), 61-68.
8. Rodrigues, J.C.; de Souza, W. Ultrastructural Alterations in Organelles of Parasitic Protozoa Induced by Different Classes of Metabolic Inhibitors. Curr. Pharm. Des., 2008, 14(9), 925-938.
9. Brana, M. F.; Sánchez-Migallon, A. Anticancer drug discovery and pharmaceutical chemistry: a history. Clin. Transl. Oncol., 2006, 8(10), 717-728.
10. Cacho, M.; Garcia, M. L.; Mayoral, E. P.; Lopez, B.; de Pascual-Teresa, B., Ramos, A.; Acero, N.; Llenares, F.; Muñoz-Mingarro, D.; Lozach, O.; Meijer, L. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases. J. Med. Chem., 2005, 48(22), 6843-6854.
11. Gaagjee, A.; Lin, X.; Kisliuk, R. L.; McGuire, J. J. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin- 6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl- 4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents. J. Med. Chem., 2005, 48(23), 7215-7222.
12. Ballard, P.; Barlaam, B. C.; Bradbury, R. H.; Dishington, A.; Hennequin L.; Hickinson, D. M.; Hollingsworth, I.; Kettle, J. G.; Klinowska, T.; Ogilvie, D. J.; Pearson, S. E.; Scott, J. S.; Suleman, A.; Whittaker, R.; Williams, E. J.; Wood, R.; Wright, L. Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorg. Med. Chem. Lett., 2007, 17(22), 6326-6329.
13. Bondock, S.; Rabie, R.; Etman, H.A.; Fadda, A.A. Synthesis and antimicrobial activity of some new heterocycles incorporating antipyrine moiety. Eur. J. Med. Chem., 2007, 23, (in press).
14. Sing, B; Sahu, P.M.; Jain, S.C.; Singh, S. Estimation of naphthaquinones from Arnebia hispidissima (Lehm.) DC. In vivo and in vitro. I. Anti-inflammatory screening. Phytother. Res., 2004, 18(2), 154-159.
15. Gürsoy, A.; Demirayak, S.; Capan, G.; Erol, K.; Vurual, K. Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents. Eur. J. Med. Chem., 2000, 35(3), 359-364.
16. Turan-Zitouni, G.; Sivaci, M.; Kilic, F.S.; Erol, K. Synthesis of some triazolyl-antipyrine derivatives and investigation of analgesic activity Eur. J. Med. Chem., 2001, 36(7-8), 685-689.
17. Gaagjee, A.; Li, X.; Yang, J.; Kisliuk, R. L. Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors. J. Med. Chem., 2008, 51(1), 68-76.
18. Metwally, M.A.; Abdel Latif, E.; Amer, F.A. Synthesis of some new phenylthiocarbamoyl 2-pyrazolin-5-ones of pharmaceutical interest. Boll. Chim. Farm., 2000, 139(5), 213-216.
19. Magán, R.; Marín, C.; Rosales, M.J.; Barrera, M.; Salas, J.M.; S∠achez-Moreno, M. Activities of Pt(II) and Ru (III) Triazole-pyrimidine complexes against Trypanosoma cruzi and T. brucei brucei. Pharmacol., 2004, 70(2), 83-90
20. Magán, R.; Marín, C.; Rosales, M.J.; Salas, J.M.; Sánchez-Moreno, M. Therapeutic Potential of New Pt(II) and Ru(III) Triazole-Pyrimidine Complexes against Leishmania donovani. Pharmacol., 2005, 73(1), 41-48.
21. Maldonado, C. R.; Quirós, M.; Salas, J. M. Copper(II) complexes with 1,2,4-triazolo[1,5-a] pyrimidine and its 5,7-dimethyl derivative. Polyhedron, 2008, (in press).
22. Luque, F.; Femández-Ramos, C.; Entrala, E.; Rosales, M.J.; Navarro, J.A.; Romero, M.A.; Salas-Peregrín, J.M.; Sánchez-Moreno, M. In vitro evaluation of newly synthesised [1,2,4]triazolo [1,5-a] pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli. Comp. Biochem. Physiol., 2000, 126(1), 39-44.
23. González, P.; Marín, C.; Rodríguez-González, I., Hitos, A.B.; Rosales, M.J.; Reina, M.; Díaz, J.G.; González.Coloma, A.; Sánchez-Moreno, M. In vitro activity of C20 diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. Int. J. Antimicrob. Agents, 2004, 25(2), 136-141.
24. Osuna, A.; Adroher, F.J.; Lupiañez. J.A. Influence of electrolytes and non-electrolytes on growth and differentiation of Trypanosoma cruzi. Cell. Differ. Dev., 1990, 30(2), 89-95.
25. Fernandez-Becerra, C.; Sánchez-Moreno, M.; Osuna, A.; Opperdoes, F.R. Comparative aspects of energy metabolism in plant trypanosomatids. J. Eukaryotic Microbiol., 1997, 44(5), 523-529.
26. Bringaud, F.; Riviere, L.; Coustou, V. Energy metabolism of Trypanosomatids: adaptation to available carbon sources. Mol. Biochem. Parasitol., 2006, 149(1), 1-9.
27. Ginger, M. Trypanosomatid biology and euglenozoan evolution: new insights and shifting paradigms revealed through genome sequencing. Protist., 2005, 156(4), 377-292.
28. Hannaert, V.; Bringaud, F.; Opperdoes, F. R.; Michels, P. A. Evolution of energy metabolism and its compartmentation in Kinetoplastida. Kinetoplastid. Biol. Dis., 2003, 2(1), 1-30.
29. Van HeIlemond, J.J.; Bakker, B.M.; Tielens, A.G. Energy metabolism and compartmentation in Trypanosoma brucei. Adv. Microb. Physiol., 2005, 50, 199-226
30. Turrens, J. More differences in energy metabolism between Trypanosomatidae. Parasitol. Today, 1999, 15(8), 346-348.
31. Tielens, A.G.; Van Hellemond, J.J. Differences in energy metabolism between Trypanosomatidae. Parasitol. Today, 1998, 14(7), 265-272.